Related Experiment Video
Updated: Nov 19, 2025
06:57
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
9.4K
Lung Microbiome in Cystic Fibrosis
Filippo Scialo1,2, Felice Amato2,3, Gustavo Cernera2,3
1Dipartimento di Scienze Mediche Traslazionali, University of Campania "L. Vanvitelli", 80131 Napoli, Italy.
Life (Basel, Switzerland)
|January 30, 2021
Summary
Cystic fibrosis (CF) impairs lung health by affecting the lung microbiome. Understanding these microbial interactions could lead to new CF therapies.
Area of Science:
- Microbiology
- Pulmonary Medicine
- Genetics
Background:
- Cystic Fibrosis (CF) is characterized by defective mucociliary clearance due to CFTR gene mutations.
- This defect leads to pathogen colonization, recurrent inflammation, and lung function decline in CF patients.
- A common feature in CF is the progressive reduction in lung microbiome diversity.
Purpose of the Study:
- To explore the role of the lung microbiome in cystic fibrosis.
- To understand the interactions between microbial components and the lung environment in CF.
- To identify potential therapeutic targets within the lung microbiome for CF.
Main Methods:
- This study reviews current understanding of the lung microbiome in CF.
- It analyzes the impact of CFTR dysfunction on microbial composition and lung physiology.
- The review discusses the challenges and future directions in CF microbiome research.
Main Results:
- CFTR malfunctioning significantly alters the lung microbiome, reducing its diversity.
- Altered lung microbiome contributes to inflammation and disease progression in CF.
- Interactions within the CF lung microbiome are complex and not fully understood.
Conclusions:
- The lung microbiome plays a critical role in maintaining lung health, even in CF.
- Further research into CF lung microbiome dynamics is essential.
- Targeting the lung microbiome offers a promising avenue for developing novel CF therapies.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
550
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
550
01:24Cystic Fibrosis: Management
314
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
314
01:29Bacterial Flora of the Large Intestine
979
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
979